Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Panacea Life Sciences Hldgs Inc (EXDID)

Panacea Life Sciences Hldgs Inc (EXDID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Panacea Life Sciences Hldgs Inc 80 NE 4th Avenue Suite 28 Delray Beach FL 33483 USA

www.exactusinc.com P: 804-205-5036

Description:

Panacea Life Sciences is involved in production of legal, trace THC, hemp-derived cannabinoid products for consumers and pets. The company produces soft gels, gummies, tinctures, sublingual tablets, cosmetics and other topicals for purchase online and in stores as well as in smart kiosk vending machines. Panacea Life Sciences, formerly known as Exactus Inc., is based in DELRAY BEACH, FL.

Key Statistics

Overview:

Market Capitalization, $K 21,564
Shares Outstanding, K 21,564
Annual Sales, $ 2,070 K
Annual Net Income, $ -9,460 K
Last Quarter Sales, $ 5,070 K
Last Quarter Net Income, $ 120 K
60-Month Beta 3.97
% of Insider Shareholders 65.00%
% of Institutional Shareholders 0.12%
Float, K 7,547
% Float 35.00%

Growth:

1-Year Return -55.36%
3-Year Return -89.85%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 12/01/21
Earnings Per Share ttm -1.12
EPS Growth vs. Prev Qtr -33.33%
EPS Growth vs. Prev Year 20.01%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-28 on 10/28/21

EXDID Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -443.21%
Return-on-Assets % -108.65%
Profit Margin % -457.00%
Debt/Equity 0.00
Price/Sales 10.41
Price/Cash Flow N/A
Price/Book 2.59
Book Value/Share 0.56
Interest Coverage -9.94
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar